A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen- specific induction

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6199-6206

  Beatty, Julia A ^a   Willett, Brian J ^a   Gault, Elizabeth A ^a   Jarrett, Oswald ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CAT; CYTOTOXIC T LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0029793257     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6199-6206.1996     Document Type: Article

References (67)

1. Ackley, C. D., J. K. Yamamoto, N. Levy, N. C. Pedersen, and M. D. Cooper. 1990. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:5652-5675.
2. Autran, B., C. M. Mayaud, M. Raphael, F. Plata, M. Denis, A. Bourgin, J. M. Guillon, P. Debre, and G. Akoun. 1988. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 2:179-183.
3. Autran, B., B. Sadat-Sowti, F. Hadida, A. Parrot, J. M. Guillon, F. Plata, C. Mayaud, and P. Debré. 1991. HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and down regulation. Res. Virol. 142: 113-118.
4. Avrameas, A., A. D. Strosberg, A. Moraillon, P. Sonigo, and G. Pancino. 1993. Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Res. Virol. 144:209-218.
5. Beebe, A. M., N. Dua, T. G. Faith, P. F. Moore, N. C. Pedersen, and S. Dandekar. 1994. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68:3080-3091.
6. Bollinger, R. C. J., R. L. Kline, H. L. Francis, M. W. Moss, J. G. Bartlett, and T. C. Quinn. 1992. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J. Infect. Dis. 165:913-916.
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
8. Brooks, C. G. 1983. Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes. Nature (London) 305:155-158.
9. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
10. Cheynier, R., P. Langlade-Demoyen, M. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211-2217.
11. Crandell, R. A., and E. W. Despeaux. 1959. Cytopathology of feline viral rhinotracheitis virus in tissue cultures of feline renal cells. Proc. Soc. Exp. Biol. Med. 101:494-497.
12. De Maria, A., C. Cirillo, and L. Moretta. 1994. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J. Infect. Dis. 170:1296-1299.
13. Fevereiro, M., C. Roneker, A. Laufs, L. Tavares, and F. de Noronha. 1991. Characterisation of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralising antibody activity. J. Gen. Virol. 72:617-622.
14. Flynn, J. N., J. A. Beatty, C. A. Cannon, E. B. Stephens, M. J. Hosie, J. C. Neil, and O. Jarrett. 1995. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 11:1107-1113.
15. Flynn, J. N., C. A. Cannon, J. A. Beatty, M. Mackett, M. A. Rigby, J. C. Neil, and O. Jarrett. 1994. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J. Virol. 68:5835-5844.
16. Flynn, J. N., C. A. Cannon, G. Reid, M. A. Rigby, J. C. Neil, and O. Jarrett. 1995. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology 85:171-175.
17. Gardner, M. B. 1991. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res. 15:267-286.
18. Gotch, F. M., D. F. Nixon, N. Alp, A. McMichael, and L. K. Borysiewicz. 1990. High frequency of memory and effector gag-specific cytotoxic T lymphocytes in HIV-seropositive individuals. Int. Immunol. 2:707-712.
19. Hannant, D., and J. A. Mumford. 1989. Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet. Immunol. Immunopathol. 21:327-337.
20. Hayes, K. A., L. J. Lafrado, J. G. Erickson, J. M. Marr, and L. E. Mathes. 1993. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats. J. Acquired Immune Defic. Syndr. 6:127-134.
21. Hayes, K. A., J. G. Wilkinson, R. Frick, S. Francke, and L. E. Mathes. 1995. Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats. J. Acquired Immune Defic. Syndr. 9:114-122.
22. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452-462.
23. Hosie, M. J. 1991. Studies on feline immunodeficiency virus. Ph.D. thesis. University of Glasgow, Glasgow, United Kingdom.
24. Hosie, M. J., and O. Jarrett. 1990. Serological responses of cats to feline immunodeficiency virus. AIDS 4:215-220.
25. Jarrett, O., J. K. Yamamoto, and J. C. Neil. 1990. Feline immunodeficiency virus as a model for AIDS vaccination. AIDS 4:S163-S165.
26. Kageyama, S., O. Yamada, S. S. Mohammad, S. Hama, N. Hattori, M. Asanaka, E. Nakayama, T. Matsumoto, F. Higuchi, T. Kawatani, and T. Kurimura. 1988. An improved method for the detection of HIV antigen in the blood of carriers. J. Virol. Methods 22:125-131.
27. Kane, K. P., and W. R. Clark. 1986. Class I MHC antigens in the generation and expression of promiscuous cytotoxic cell function. J. Immunol. 137: 3080-3086.
28. Kindt, T. J., V. M. Hirsch, P. R. Johnson, and S. Sawasdikosol. 1992. Animal models for acquired immunodeficiency syndrome. Adv. Immunol. 52:425-474.
29. Klein, M. R., C. A. Van Baalen, A. M. Holwerda, S. R. K. Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
30. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994 Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
31. Lamhamedi-Cherradi, S., B. Culmann Penciolelli, B. Guy, T. D. Ly, C. Coujard, J. G. Guillet, and E. Gomard. 1995. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9:421-426.
32. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-speciflc cytotoxic T lymphocytes in non-infected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293-1297.
33. McCheyney, M., F. Tanneau, A. Regnault, M. P. Kieny, and Y. Rivière. 1990 Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur. J. Immunol. 20:215-220.
34. Miyazawa, T., T. Furuya, S. Itagaki, V. Tohya, E. Takahashi, and T. Mikami. 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108:131-135.
35. Nishanian, P., K. R. Huskins, S. Stehn, R. Detels, and J. L. Fahey. 1990. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Infect. Dis. 162:21-28.
36. + T-lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc. Natl. Acad. Sci. USA 87:4818-4848.
37. Plata, F., B. Autran, L. P. Martins, S. Wain-Hobson, M. Raphaël, C. Mayaud, M. Denis, J. M. Guillon, and P. Debré. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (London) 328:348-351.
38. Reid, G., M. Rigby, M. McDonald, M. Hosie, J. C. Neil, and O. Jarrett. 1991. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS 5:1477-1483.
39. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil, and N, J. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
40. Rigby, M. A., E. C. Holmes, M. Pistello, A. Mackay, A. J. Leigh Brown, and J. C. Neil. 1993. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J. Gen. Virol. 74:425-436.
41. Rinaldo, C. R. J., L. A. Beltz, X. L. Huang, P. Gupta, Z. Fan, and D. J. Torpey III. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retroviruses 11:481-489.
42. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M.-P. Kieny, J.-J. Fournel, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:2270-2277.
43. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
44. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfectcd infant. Lancet 341:860-861.
45. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterisation of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
46. Sethi, K. K., H. Naher, and I. Stroehmann. 1988. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature (London) 335:178-181.
47. + T cells. J. Immunol. 132:584-593.
48. Siebelink, K. H. J., I. Chu, G. F. Rimmelzwaan, K. Wiejer, R. van Herwijnen, P. Knell, H. F. Egberink, M. Bosch, and A. D. M. E. Osterhaus. 1990. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res. Hum. Retroviruses 6:1373-1378.
49. Song, W., E. W. Collisson, P. M. Billingsley, and W. C. Brown. 1992. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66:5409-5417.
50. Song, W., E. W. Collisson, J. Li, A. M. Wolf, J. H. Elder, C. K. Grant, and W. C. Brown. 1995. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. Virology 209:390-399.
51. Sparger, E. E., P. A. Luciw, J. H. Elder, J. K. Yamamoto, L. J. Lowenstine, and N. C. Pedersen. 1989. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 3:S43-S49.
52. Stephens, E. B., E. J. Butfiloski, and E. Monck. 1992. Analysis of the amino terminal presequence of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology 190:569-578.
53. Teh, H., and M. Yu. 1983. Activation of nonspecific killer cells by interleukin 2-containing supernatants. J. Immunol. 131:1827-1833.
54. Tompkins, M. B., G. K. Ogilvie, R. A. Franklin, K. W. Kelley, and W. A. Tompkins. 1987. Induction of IL-2 and lymphokine activated killer cells in the cat. Vet. Immunol. Immunopathol. 16:1-10.
55. Toyosaki, T., T. Miyazawa, T. Furuya, K. Tomonaga, Y.-S. Shin, M. Okita, Y. Kawaguchi, C. Kai, S. Mori, and T. Mikami. 1993. Localisation of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection. Arch. Virol. 131:335-347.
56. Tozzini, F., D. Matteucci, P. Bandecchi, F. Baldinotti, A. Poli, M. Pistello, K. H. J. Siebelink, L. Ceccherininelli, and M. Bendinelli. 1992. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. J. Virol. Methods 37:241-252.
57. + effector cells armed in vivo with cytophilic antibody. J. Immunol. 142:1177-1182.
58. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 328:345-348.
59. Weinhold, K. J., H. K. Lyerly, T. J. Matthews, D. S. Tyler, P. M. Ahearne, K. C. Stine, A. J. Langlois, D. T. Durack, and D. P. Bolognesi. 1988. Cellular anti-gp120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet i:902-904.
60. Willett, B., M. J. Hosie, T. Dunsford, J. C. Neil, and O. Jarrett. 1991 Productive infection of helper T lymphocytes with FIV is accompanied by reduced expression of CD4. AIDS 5:1469-1475.
61. Willett, B. J., and J. J. Callanan. 1995. The expression of leucocyte differentiation antigens in the feline immune system, p. 3-15. In B. J. Willett and O. Jarrett (ed.), Feline immunology and immunodeficiency. Oxford University Press, Oxford.
62. Willett, B. J., M. J. Hosie, O. Jarrett, and J. C. Neil. 1994. Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 79:228-233.
63. Willett, B. J., M. J. Hosie, J. C. Neil, and O. Jarrett. 1993. Early expansion of a CD8+ subset follows infection with FIV. Immunology 78:1-6.
64. Yamamoto, J. K., E. E. Sparger, E. W. Ho, P. R. Andersen, T. P. O'Connor, C. P. Mandell, L. Lowenstine, R. Munn, and N. C. Pedersen. 1988. Pathogenesis studies of experimentally induced feline immunodeficiency virus infection. Am. J. Vet. Res. 49:1246-1258.
65. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.
66. Young, J. D. E., and Z. A. Cohn. 1987. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv. Immunol. 41:269-332.
67. + LAK cells from cats infected with feline immunodeficiency virus. J. Leukocyte Biol. 58:423-431.